Osaic Holdings’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $317K | Sell |
29,586
-12,282
| -29% | -$132K | ﹤0.01% | 3194 |
|
|
2025
Q1 | $359K | Buy |
41,868
+10,386
| +33% | +$89.1K | ﹤0.01% | 3153 |
|
|
2024
Q4 | $338K | Buy |
31,482
+22,698
| +258% | +$244K | ﹤0.01% | 3142 |
|
|
2024
Q3 | $49.9K | Buy |
8,784
+6,446
| +276% | +$36.6K | ﹤0.01% | 4736 |
|
|
2024
Q2 | $9.87K | Sell |
2,338
-10,726
| -82% | -$45.3K | ﹤0.01% | 5729 |
|
|
2024
Q1 | $66.5K | Sell |
13,064
-8,456
| -39% | -$43K | ﹤0.01% | 4518 |
|
|
2023
Q4 | $200K | Buy |
21,520
+8,591
| +66% | +$80K | ﹤0.01% | 3926 |
|
|
2023
Q3 | $84.7K | Sell |
12,929
-213
| -2% | -$1.4K | ﹤0.01% | 4623 |
|
|
2023
Q2 | $107K | Sell |
13,142
-1,652
| -11% | -$13.5K | ﹤0.01% | 4383 |
|
|
2023
Q1 | $127K | Sell |
14,794
-1,844
| -11% | -$15.8K | ﹤0.01% | 4242 |
|
|
2022
Q4 | $154K | Buy |
16,638
+7,065
| +74% | +$65.6K | ﹤0.01% | 4083 |
|
|
2022
Q3 | $99K | Sell |
9,573
-1,813
| -16% | -$18.7K | ﹤0.01% | 4380 |
|
|
2022
Q2 | $114K | Sell |
11,386
-5,645
| -33% | -$56.5K | ﹤0.01% | 4305 |
|
|
2022
Q1 | $294K | Sell |
17,031
-2,056
| -11% | -$35.5K | ﹤0.01% | 3700 |
|
|
2021
Q4 | $330K | Sell |
19,087
-35,609
| -65% | -$616K | ﹤0.01% | 3459 |
|
|
2021
Q3 | $981K | Buy |
54,696
+22,694
| +71% | +$407K | ﹤0.01% | 2363 |
|
|
2021
Q2 | $722K | Buy |
32,002
+21,857
| +215% | +$493K | ﹤0.01% | 2637 |
|
|
2021
Q1 | $152K | Buy |
10,145
+3,758
| +59% | +$56.3K | ﹤0.01% | 3985 |
|
|
2020
Q4 | $35K | Sell |
6,387
-3,850
| -38% | -$21.1K | ﹤0.01% | 4776 |
|
|
2020
Q3 | $46K | Sell |
10,237
-2,750
| -21% | -$12.4K | ﹤0.01% | 4340 |
|
|
2020
Q2 | $64K | Sell |
12,987
-450
| -3% | -$2.22K | ﹤0.01% | 3998 |
|
|
2020
Q1 | $42K | Buy |
+13,437
| New | +$42K | ﹤0.01% | 4070 |
|